Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Flerie Invest AB is a venture capital firm specializing in early-stage investments in life science, biotech, and pharma companies. The firm invests globally, including in Europe, the Nordic region, the United States, and Israel. Flerie focuses on drug development and associated tools or applications addressing major medical challenges. The company manages a portfolio of around 30 companies and aims to support pioneering organizations with resources and expertise.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Flerie Invest AB's primary investment focus?
- Flerie Invest AB primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and investment rounds concentrated in this area.
- Can you name a notable company in Flerie Invest AB's portfolio?
- KAHR Medical, a company developing fusion proteins for treating cancer and autoimmune diseases, is a notable company in Flerie Invest AB's portfolio. KAHR Medical has raised $118.27M in funding.
- What is Flerie Invest AB's typical investment range?
- Flerie Invest AB typically invests between $7.5M and $46.5M per round.
- When was Flerie Invest AB founded?
- Flerie Invest AB was founded in 2019.
- What is Flerie Invest AB's most recent investment activity?
- Flerie Invest AB's most recent recorded investment round occurred in June 2021.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2010 |
|---|